Following COVID-19 vaccination, the SARS-CoV-2 spike protein is detectable in plasma and triggers inflammation in epithelial and mucosal sites like the gut [54, 55], and its association with immunity and the gut dysbiosis has been described [55, 56]. This evidence concerns the gene PROS1 and COVID-19.